Cargando…
MON-470 Pharmacological Inhibition of LAT1 Suppresses Proliferation and Hormone Synthesis in Rat Pituitary Tumor GH4 Cells [cc1] Synthesis May Be Better as Only mRNAs Were Measured
Pituitary tumors (PTs) occur in almost 17 % of the population and they represent about 10 % of all intracranial tumors. Growth hormone-producing pituitary tumors account for about 12% of pituitary tumors. At present, many patients with this type of pituitary tumor suffer from symptoms and complicati...
Autores principales: | Sato, Motoyasu, Wang, Jason, Hayashi, Keitaro, Endou, Hitoshi, Sugimoto, Hiroyuki, Chik, Constance, Tateno, Toru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550769/ http://dx.doi.org/10.1210/js.2019-MON-470 |
Ejemplares similares
-
MON-406 Two Cases of Aggressive Corticotroph Pituitary Tumors Treated with Capecitabine and Temozolomide
por: Tateno, Tae, et al.
Publicado: (2019) -
LBODP078 Role Of Ire1a-xbp1 Pathway In Rodent Functional Pituitary Tumor Cells.
por: Nezu, Masahiro, et al.
Publicado: (2022) -
MIF Inhibition Suppresses Cell Viability and Induces Apoptosis via the ATF4-CHOP Pathway in Mouse Pituitary AtT-20 Cells
por: Wang, Jason, et al.
Publicado: (2021) -
MON-473 Growth Hormone (GH) Impacts the Gut Microbial Profile: the Presence of Unique Bacterial Genera in Mouse Lines with Altered GH Action
por: Jensen, Elizabeth, et al.
Publicado: (2019) -
MON-265 Once-Weekly Somapacitan in Japanese Adults with GH Deficiency Was Well Tolerated, with Similar Efficacy to Daily GH: A Randomized Trial
por: Otsuka, Fumio, et al.
Publicado: (2020)